Public health implications of SARS-CoV-2 variants of concern: a rapid scoping review
Open Access
Abstract
Objectives The four SARS-CoV-2 variants of concern (VOC; Alpha, Beta, Gamma and Delta) identified by May 2021 are highly transmissible, yet little is known about their impact on public health measures. We aimed to synthesise evidence related to public health measures and VOC. Design A rapid scoping review. Data sources On 11 May 2021, seven databases (MEDLINE, Embase, the Cochrane Database of Systematic Reviews, Central Register of Controlled Trials, Epistemonikos’ L-OVE on COVID-19, medRxiv, bioRxiv) were searched for terms related to VOC, public health measures, transmission and health systems. No limit was placed on date of publication. Eligibility criteria Studies were included if they reported on any of the four VOCs and public health measures, and were available in English. Only studies reporting on data collected after October 2020, when the first VOC was reported, were included. Data extraction and synthesis Titles, abstracts and full-text articles were screened by two independent reviewers. Data extraction was completed by two independent reviewers using a standardised form. Data synthesis and reporting followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews guidelines. Results Of the 37 included studies, the majority assessed the impact of Alpha (n=32) and were conducted in Europe (n=12) or the UK (n=9). Most were modelling studies (n=28) and preprints (n=28). The majority of studies reported on infection control measures (n=17), followed by modifying approaches to vaccines (n=13), physical distancing (n=6) and either mask wearing, testing or hand washing (n=2). Findings suggest an accelerated vaccine rollout is needed to mitigate the spread of VOC. Conclusions The increased severity of VOC requires proactive public health measures to control their spread. Further research is needed to strengthen the evidence for continued implementation of public health measures in conjunction with vaccine rollout. With no studies reporting on Delta, there is a need for further research on this and other emerging VOC on public health measures.Keywords
All Related Versions
Funding Information
- Canadian Institutes of Health Research (Grant #: CKS-174105)
This publication has 59 references indexed in Scilit:
- The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Covid-19: UK approves Pfizer and BioNTech vaccine with rollout due to start next weekBMJ, 2020
- First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessmentThe Lancet, 2020
- WHO Declares COVID-19 a Pandemic2020
- Using rapid reviews to strengthen health policy and systems and progress towards universal health coverageBMJ Global Health, 2019
- Effectiveness of hand hygiene practices in preventing influenza virus infection in the community setting: A systematic reviewCanada Communicable Disease Report, 2019
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- Panethnic Differences in Blood Pressure in Europe: A Systematic Review and Meta-AnalysisPLOS ONE, 2016
- Guidance for conducting systematic scoping reviewsJBI Evidence Implementation, 2015
- Evidence summaries: the evolution of a rapid review approachSystematic Reviews, 2012